|
Model Number B3301542 |
Device Problems
High impedance (1291); Device Contamination with Chemical or Other Material (2944)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/08/2022 |
Event Type
malfunction
|
Event Description
|
It was reported from a manufacturer representative that high impedance was observed during stage 1 surgery while attaching testing cable for intra-operative awake testing on patient.Monopolar testing was done using the testing cable at first and there were no problems.Surgeon elected to do micro-electrical recording (mer) after the testing so the testing cable was disconnected, the lead was removed, and alpha omega mer was set up and performed.After mer, testing cable was reattached and a high impedance warning was given while using external neurostimulator (ens).It was consistently showing high impedance on lead 1c in monopolar and bipolar.The canula was 25mm above target.It was theorized that there was something with the patient's anatomy that was causing the high impedance, or perhaps there was some blood or fluid in the lead tract which was causing the high impedance.The testing cable was detached and reattached repeatedly.A different ens was used.A new testing cable was opened and used.A new lead was opened and used.Every time it showed the same impedances, high on 1c.The target/lead was raised by one millimeter and it gave normal impedances.It was lo wered back to the original target and the same high impedances were shown.It was raised one millimeter again and the impedances were all normal.Implant was then done at the new target, 1 mm above previous target.The lead ended up not being implanted as the surgeon wanted to have a marked and unmarked lead implanted, and two marked leads were opened because the left side of the brain was being implanted.The issue was resolved.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
H3: analysis of lead (b)(6) found no anomalies.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|